Biomarkers in DILI: One More Step Forward

Despite being relatively rare, drug-induced liver injury (DILI) is a serious condition, both for the individual patient due to the risk of acute liver failure, and for the drug development industry and regulatory agencies due to associations with drug development attritions, black box warnings, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Robles-Díaz, Mercedes, Medina-Caliz, Inmaculada, Stephens, Camilla, Andrade, Raúl J., Lucena, M. Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992729/
https://www.ncbi.nlm.nih.gov/pubmed/27597831
http://dx.doi.org/10.3389/fphar.2016.00267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992729/
https://www.ncbi.nlm.nih.gov/pubmed/27597831
http://dx.doi.org/10.3389/fphar.2016.00267

Ejemplares similares